glp 1 mech of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1: Actions on Beta-cell Mass

Kaul S, Bolger AF, Herrington D, Giugliano RP, Eckel RH

Metoclopramide and erythromycin are the two most commonly used agents used to manage gastroparesis and there is potential that the GLP-1 agonists will oppose the prokinetic effects of these agents Corticosteroids Corticosteroids are notorious for raising blood sugars which could directly oppose the blood sugar lowering effects of GLP-1 agonists

Your provider should establish realistic expectations based on your baseline lipid profile

L-carnitine is involved in fat utilization for energy, so its sometimes included in weight-management discussions

A small effect of the injection site shows up in absorption research, with bioavailability roughly 12 percent lower in the thigh compared with the abdomen